Spero Therapeutics (SPRO) Minority Interest (2016 - 2019)
Spero Therapeutics' (SPRO) quarterly Minority Interest came in at $355000.0 in Q3 2019, little changed YoY from $355000.0 in Q3 2018, and little changed on a QoQ basis from $355000.0 in Q2 2019.
Spero Therapeutics (SPRO) Minority Interest (2016 - 2019) Analysis & Trends
Spero Therapeutics (SPRO) has 4 years of Minority Interest data on file, last reported at $355000.0 in Q3 2019.
- Quarterly Minority Interest changed 0.0% year-over-year to $355000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $355000.0 (changed 0.0% YoY) and the FY2018 annual result came in at $355000.0, changed 0.0% from the prior year.
- Minority Interest held at $355000.0 in Q3 2019, from $355000.0 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $6.4 million in Q2 2017 to a low of -$3.8 million in Q4 2016.
- A 4-year average of $526636.4 and a median of $355000.0 in 2017 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2017 — Minority Interest soared 109.32% — and 2018, when it slumped 94.45%.
- Tracing SPRO's Minority Interest over 4 years: stood at -$3.8 million in 2016, then jumped by 109.32% to $355000.0 in 2017, then changed by 0.0% to $355000.0 in 2018, then changed by 0.0% to $355000.0 in 2019.
- The last three Minority Interest figures came in at $355000.0 (Q3 2019), $355000.0 (Q2 2019), and $355000.0 (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Spero Therapeutics | 70.14 Mn | 19.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 355,000.00 |
| Jun 30, 2019 | 355,000.00 |
| Mar 31, 2019 | 355,000.00 |
| Dec 31, 2018 | 355,000.00 |
| Sep 30, 2018 | 355,000.00 |
| Jun 30, 2018 | 355,000.00 |
| Mar 31, 2018 | 355,000.00 |
| Dec 31, 2017 | 355,000.00 |
| Sep 30, 2017 | 361,000.00 |
| Jun 30, 2017 | 6.40 Mn |
| Dec 31, 2016 | -3.81 Mn |